Evolution of tumor cells during AsiDNA treatment results in energy exhaustion, decrease in responsiveness to signal, and higher sensitivity to the drug
Pierre‐Marie Girard(Assistance Publique – Hôpitaux de Paris), Marie Dutreix(Centre National de la Recherche Scientifique)
Cited by 6
Related Papers
Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage Response
|PLoS ONE|2009|80
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
|British Journal of Cancer|2016|35
Singlet Oxygen-Mediated Oxidation during UVA Radiation Alters the Dynamic of Genomic DNA Replication
|PLoS ONE|2015|34
The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
|NAR Cancer|2024|8
First-in-human phase I study of the DNA repair inhibitor DT01 in combination with radiotherapy in patients with in transit melanoma.
|Journal of Clinical Oncology|2015|1